Tonix Pharmaceuticals Holding Corp.
TNXP
$13.22
$1.2410.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.19M | -46.91M | -32.01M | -28.27M | -16.83M |
| Total Depreciation and Amortization | 555.00K | 488.00K | 461.00K | 483.00K | 493.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 65.00K |
| Total Other Non-Cash Items | 1.97M | 1.14M | 2.15M | 5.54M | 2.97M |
| Change in Net Operating Assets | -4.65M | 5.63M | 616.00K | 7.42M | -3.28M |
| Cash from Operations | -42.32M | -39.65M | -28.78M | -14.83M | -16.58M |
| Capital Expenditure | -1.69M | -1.87M | -962.00K | -527.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 853.00K | 0.00 | -2.01M | -- |
| Cash from Investing | -1.69M | -1.02M | -962.00K | -2.54M | -6.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -9.65M |
| Issuance of Common Stock | 20.88M | 69.95M | 97.85M | 14.38M | 64.50M |
| Repurchase of Common Stock | -- | -7.81M | 0.00 | -2.90M | -3.05M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -676.00K | -3.00M | -2.99M | -487.00K | -2.27M |
| Cash from Financing | 20.21M | 59.14M | 94.86M | 10.99M | 49.53M |
| Foreign Exchange rate Adjustments | 6.00K | -14.00K | -4.00K | -4.00K | -9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.80M | 18.46M | 65.11M | -6.38M | 32.94M |